Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ambroxol inhalation solution for mucus symptoms in lower respiratory tract infection
CTR20130370Phase 3Active
- Sponsor
- Hanmi Pharmaceutical
- Start
- Sep 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ambroxol in pulmonary infection, chronic bronchitis (CB), pneumonia, chronic obstructive pulmonary disease (COPD), asthmatic bronchitis, sponsored by Hanmi Pharmaceutical. Started Sep 2013; status: active.
02
Drugs
ambroxol
03
Conditions
pulmonary infectionchronic bronchitis (CB)pneumoniachronic obstructive pulmonary disease (COPD)asthmatic bronchitis
Beyond the preview
Go deeper on CTR20130370.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20130370.